Diabetes Mellitus(ISSN:2072-0351)

Test Temporal and spatial distribution characteristics of microplastics and their influencing factors in Guanzhong section of Weihe River Basin

Test Microplastics (MPs), a new type of pollutant, pose a significant threat to the environment at high concentrations. One of the primary sources of MPs in the ocean is river runoff, highlighting the need to investigate the spatial and temporal variations of MPs in rivers that flow into the sea, as well as their contributing factors. In this study, we analyzed MPs distribution and their influe

The organoprotective effects of finerenone in patients with cardiorenal metabolic syndrome

Type 2 diabetes mellitus (T2DM) is associated with hyperactivity of the renin-angiotensin-aldosterone system (RAAS), leading to increased aldosterone levels in the blood. This can result in the development and progression of chronic kidney disease (CKD) and congestive heart failure (CHF). High aldosterone levels, in turn, contribute to insulin resistance, microcirculatory disorders, mitochondri

The illusion of accuracy: a critical analysis of continuous glucose monitoring systems quality assessment methods

Continuous glucose monitoring (CGM) has been used for over 15 years in the Russian Federation as a method of self-monitoring glucose levels in patients with diabetes. The main characteristic of CGM devices, ensuring their effective and safe use, is the accuracy of readings. Currently, there are no uniform regulatory documents defining the minimum acceptable accuracy indicators for CGM systems.

Chronic kidney disease in patients with diabetes mellitus: new challenges

Chronic kidney disease (CKD) is a supranosological concept, defined as a disorder of the structure and/or function of the kidneys for 3 months or more that leads to health consequences. CKD develops in 20–40% of patients with diabetes mellitus (DM). Dynamic analysis of epidemiological indicators of CKD in patients with diabetes mellitus points to the prevalence increase of this pathology

Diabetes mellitus and psoriatic arthritis

Psoriatic arthritis (PsA) and psoriasis (PsO) are often associated with metabolic disorders including obesity, metabolic syndrome, diabetes mellitus (DM) and cardiovascular diseases (CVD). It is believed that obesity, DM, PsO and PsA have similar immunopathogenetic mechanisms. Chronic inflammation is closely associated not only with the development of PsO and PsA, but also with the formation of

Diabetes Mellitus(ISSN:2072-0351)